Related Experiment Videos
Natural cell-mediated cytotoxicity in vitiligo
M Ghoneum1, P E Grimes, G Gill
1Department of Otolaryngology, Charles R. Drew Postgraduate Medical School, Los Angeles, CA.
Journal of the American Academy of Dermatology
|October 1, 1987
Summary
Patients with vitiligo exhibit reduced natural killer (NK) cell activity against specific cancer cells, suggesting potential defects in immune surveillance that may link vitiligo to internal malignancies.
Area of Science:
- Immunology
- Dermatology
- Oncology
Background:
- Vitiligo is an autoimmune condition characterized by depigmentation of the skin.
- Natural cell-mediated cytotoxicity, primarily mediated by natural killer (NK) cells, plays a crucial role in immune surveillance against tumors.
- Previous studies have suggested a potential link between vitiligo and an increased risk of certain internal malignancies.
Purpose of the Study:
- To investigate the functional activity of natural killer (NK) cells in patients with vitiligo.
- To compare the cytotoxic response and target cell binding capacity of NK cells in vitiligo patients versus healthy controls.
- To explore the potential implications of altered NK cell function in the association between vitiligo and internal malignancies.
Main Methods:
- Peripheral blood samples were collected from 18 patients with vitiligo and 13 age-, race-, and sex-matched healthy controls.
- Natural cell-mediated cytotoxicity was assessed using the 4-hour chromium-51 (51Cr) release assay against K562 and Molt-4 target cells.
- The binding capacity of NK cells to Molt-4 target cells was evaluated.
Main Results:
- Patients with vitiligo showed a significant reduction (50-67%) in cytotoxic response against Molt-4 target cells at various effector-target ratios (p < 0.001).
- This impaired cytotoxicity correlated with an 80% decrease in the binding capacity of NK cells to Molt-4 cells (p < 0.005).
- No significant differences in cytotoxic responses were observed when using K562 target cells, indicating specificity in the NK cell defect.
Conclusions:
- Patients with vitiligo exhibit a diminished capacity for NK cell recognition and lysis of Molt-4 target cells, but not K562 cells.
- These findings suggest the presence of defective NK cell clones in vitiligo patients, potentially impairing their ability to recognize and eliminate certain tumor cells.
- The observed NK cell dysfunction may contribute to the increased susceptibility to certain internal malignancies associated with vitiligo.